HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kwon, Y. T. Articles by Varshavsky, A. Search for Related Content PubMed PubMed Citation Articles by Kwon, Y. T. Articles by Varshavsky, A. Social Bookmarking                      What's this?

J Biol Chem, Vol. 274, Issue 25, 18135-18139, June 18, 1999

Bivalent Inhibitor of the N-end Rule Pathway

Yong Tae Kwon, Frédéric Lévy^§, and Alexander Varshavsky

From the  Division of Biology, California Institute of Technology, Pasadena, California 91125 and the ^§ Ludwig Institute for Cancer Research, 155, ch. Des Boveresses, CH-1066 Epalinges, Switzerland

The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal residue. Ubr1p, the recognition (E3) component of the Saccharomyces cerevisiae N-end rule pathway, contains at least two substrate-binding sites. The type 1 site is specific for N-terminal basic residues Arg, Lys, and His. The type 2 site is specific for N-terminal bulky hydrophobic residues Phe, Leu, Trp, Tyr, and Ile. Previous work has shown that dipeptides bearing either type 1 or type 2 N-terminal residues act as weak but specific inhibitors of the N-end rule pathway. We took advantage of the two-site architecture of Ubr1p to explore the feasibility of bivalent N-end rule inhibitors, whose expected higher efficacy would result from higher affinity of the cooperative (bivalent) binding to Ubr1p. The inhibitor comprised mixed tetramers of -galactosidase that bore both N-terminal Arg (type 1 residue) and N-terminal Leu (type 2 residue) but that were resistant to proteolysis in vivo. Expression of these constructs in S. cerevisiae inhibited the N-end rule pathway much more strongly than the expression of otherwise identical -galactosidase tetramers whose N-terminal residues were exclusively Arg or exclusively Leu. In addition to demonstrating spatial proximity between the type 1 and type 2 substrate-binding sites of Ubr1p, these results provide a route to high affinity inhibitors of the N-end rule pathway.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. J. Lee, K. Pal, T. Tasaki, S. Roy, Y. Jiang, J. Y. An, R. Banerjee, and Y. T. Kwon Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway PNAS, January 8, 2008; 105(1): 100 - 105. [Abstract] [Full Text] [PDF]

				T. Tasaki, L. C. F. Mulder, A. Iwamatsu, M. J. Lee, I. V. Davydov, A. Varshavsky, M. Muesing, and Y. T. Kwon A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons Mol. Cell. Biol., August 15, 2005; 25(16): 7120 - 7136. [Abstract] [Full Text] [PDF]

				Y. T. Kwon, Z. Xia, I. V. Davydov, S. H. Lecker, and A. Varshavsky Construction and Analysis of Mouse Strains Lacking the Ubiquitin Ligase UBR1 (E3alpha ) of the N-End Rule Pathway Mol. Cell. Biol., December 1, 2001; 21(23): 8007 - 8021. [Abstract] [Full Text] [PDF]

				S. A. Balogh, Y. T. Kwon, and V. H. Denenberg Varying Intertrial Interval Reveals Temporally Defined Memory Deficits and Enhancements in NTAN1-Deficient Mice Learn. Mem., September 1, 2000; 7(5): 279 - 286. [Abstract] [Full Text]

				Y. T. Kwon, S. A. Balogh, I. V. Davydov, A. S. Kashina, J. K. Yoon, Y. Xie, A. Gaur, L. Hyde, V. H. Denenberg, and A. Varshavsky Altered Activity, Social Behavior, and Spatial Memory in Mice Lacking the NTAN1p Amidase and the Asparagine Branch of the N-End Rule Pathway Mol. Cell. Biol., June 1, 2000; 20(11): 4135 - 4148. [Abstract] [Full Text]